Should you hold Aphria (APHA) stock?
May 04, 2021 · Is Aphria Inc a buy or a sell? In the last year, 2 stock analysts published opinions about APHA-T. 2 analysts recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . …
What should Aphria stock have traded at before the Tilray merger?
Apr 03, 2022 · 0 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Aphria in the last twelve months. There are currently for the stock. The consensus among Wall Street equities research analysts is that investors should "n/a" Aphria stock. View analyst ratings for Aphria or view top-rated stocks.
How much is a share of Aphria worth?
Jul 31, 2020 · What's Happening With Aphria Inc Stock Today? Aphria Inc (APHA) stock is trading at $4.71 as of 2:02 PM on Friday, Jul 31, a loss of -$0.22, or -4.37% from the previous closing price of $4.92. The stock has traded between $4.59 and $5.02 so far today. Volume today is more active than usual.
Is Aphria's stock outpacing its medical marijuana peers this year?
May 19, 2020 · Aphria Inc (APHA) stock is trading at $3.64 as of 9:31 AM on Tuesday, May 19, a rise of $0.06, or 1.68% from the previous closing price of $3.58. The stock has traded between $3.61 and $3.66 so far today. Volume today is light. So far 103,703 shares have traded compared to average volume of 7,003,986 shares.
When should I sell Aphria stock?
Aphria Inc(APHA-T) Rating Stockchase rating for Aphria Inc is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.
Should I hold or sell Aphria?
The consensus among Wall Street analysts is that investors should "hold" Aphria stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in APHA, but not buy additional shares or sell existing shares.
Is Aphria a good buy right now?
Currently, Aphria is trading at close to 0.73 times Tilray's share price. The single most compelling reason to buy Aphria stock right now is that this ratio absolutely must increase to the 0.8381 ratio included in the merger agreement.Mar 11, 2021
What will happen to my Aphria stock?
What will happen to Aphria once the arrangement is completed? Once completed, Tilray will acquire all outstanding Aphria Shares and Aphria will become a wholly-owned subsidiary of Tilray. Aphria Shares will be delisted from the TSX and NASDAQ.
Is Aphria good stock?
Aphria has a good hold in the European medical cannabis market, thanks to its German subsidiary, CC Pharma. It earns around 98% of its distribution revenue from it. Coupled with Tilray's operations in Portugal, the new entity can easily make its mark in Europe.Mar 13, 2021
Is Aphria undervalued?
Because Aphria is relatively undervalued, the long-term return of its stock is likely to be higher than its business growth, which averaged 125.7% over the past three years and is estimated to grow 26.56% annually over the next three to five years.Mar 28, 2021
Will Aphria stock become Tilray?
After Tilray's (TLRY) shareholders voted in favor of the proposed merger Aphria (APHA) last Friday, the two cannabis companies announced today the completion of the transaction.May 3, 2021
Is Sundial growers a buy?
The price has been going up and down for this period, and there has been a -18.65% loss for the last 2 weeks....Predicted Opening Price for Sundial Growers Inc. of Thursday, April 21, 2022.Fair opening price April 21, 2022Current price$0.53$0.53 (Undervalued)
What happens to Aphria shares after merger?
The deal is expected to close in the second quarter. Under the terms of the proposed deal, Aphria shareholders will receive 0.8381 of a Tilray share of class 2 common stock for each Aphria share owned.May 2, 2021
Why is Aphria delisted?
Rivals Canopy Growth Corp and Aphria Inc also moved their U.S. listings to the Nasdaq in 2020, citing lower costs. Aphria delisted this year after its reverse merger with Nasdaq-listed Tilray . Aurora's shares will start trading on the Nasdaq on May 25 under the ticker symbol “ACB.”May 13, 2021
Why is Aphria stock dropping?
Aphria stock plunged Monday after the Canadian cannabis firm missed expectations for third-quarter sales and its net loss widened. Also falling were shares of Canadian peer Tilray , which plans to merge with Aphria.Apr 12, 2021
Is Aphria a buy right now?
5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aphria in the last twelve months. There are currently 3 hold ratings and 2...
How were Aphria's earnings last quarter?
Aphria Inc. (NASDAQ:APHA) released its earnings results on Sunday, April, 11th. The company reported ($1.14) earnings per share for the quarter, mi...
What price target have analysts set for APHA?
5 brokerages have issued twelve-month target prices for Aphria's shares. Their forecasts range from $18.00 to $26.00. On average, they expect Aphri...
Who are Aphria's key executives?
Aphria's management team includes the following people: Mr. Irwin D. Simon , CEO & Chairman (Age 62, Pay $5.23M) Mr. Carl A. Merton , Chief Fin...
Who are some of Aphria's key competitors?
Some companies that are related to Aphria include STADA Arzneimittel Aktiengesellschaft (STDAF) , Canopy Growth (CGC) , Tilray (TLRY) , USANA H...
What other stocks do shareholders of Aphria own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Aphria investors own include AbbVie (ABBV) , Alibaba Grou...
What is Aphria's stock symbol?
Aphria trades on the NASDAQ under the ticker symbol "APHA."
What is Aphria's stock price today?
One share of APHA stock can currently be purchased for approximately $15.38.
How much money does Aphria make?
Aphria has a market capitalization of $4.87 billion and generates $405.96 million in revenue each year. The company earns $-63.21 million in net in...
Is Aphria a buy right now?
8 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Aphria in the last year. There are currently 5 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" Aphria stock.
What stocks does MarketBeat like better than Aphria?
Wall Street analysts have given Aphria a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Aphria wasn't one of them.
How were Aphria's earnings last quarter?
Aphria Inc. (NASDAQ:APHA) released its quarterly earnings results on Sunday, April, 11th. The company reported ($1.14) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.04) by $1.10. The business had revenue of $153.60 million for the quarter, compared to analyst estimates of $172.01 million.
What price target have analysts set for APHA?
8 brokers have issued 1 year target prices for Aphria's stock. Their forecasts range from $15.00 to $32.50. On average, they expect Aphria's share price to reach $22.00 in the next twelve months.
Who are some of Aphria's key competitors?
Some companies that are related to Aphria include STADA Arzneimittel Aktiengesellschaft (STDAF), Canopy Growth (CGC), Tilray (TLRY), Cronos Group (CRON), USANA Health Sciences (USNA), Aurora Cannabis (ACB), True Drinks (TRUU), Sundial Growers (SNDL), ChromaDex (CDXC), Canopy Rivers (RIV), HEXO (HEXO), Natural Alternatives International (NAII), MediWound (MDWD), Bon Natural Life (BON) and Grove (GRVI).#N#View all of APHA's competitors..
What other stocks do shareholders of Aphria own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Aphria investors own include AbbVie (ABBV), Alibaba Group (BABA), (CGC), Mastercard (MA), Square (SQ), Aurora Cannabis (ACB), Abbott Laboratories (ABT), Alteryx (AYX), Big Lots (BIG) and BlackRock (BLK).
Who are Aphria's major shareholders?
Aphria's stock is owned by many different institutional and retail investors. Top institutional investors include Goldman Sachs Group Inc. (0.00%), Simplex Trading LLC (0.00%), JPMorgan Chase & Co. (0.00%), Bank of Montreal Can (0.00%), HAP Trading LLC (0.00%) and Wolverine Trading LLC (0.00%).
Why are Analyst Ratings Important?
Analysts know the inner workings of the companies they follow better than anyone but the companies’ management. You can learn a lot about a company from studying the financial statements, but analysts ask questions on conference calls and understand the intricacies of each of the businesses they cover.
What's Happening With Aphria Inc Stock Today?
Aphria Inc (APHA) stock is trading at $3.64 as of 9:31 AM on Tuesday, May 19, a rise of $0.06, or 1.68% from the previous closing price of $3.58. The stock has traded between $3.61 and $3.66 so far today. Volume today is light. So far 103,703 shares have traded compared to average volume of 7,003,986 shares.
Is Tilray the Right Partner?
Aphria’s pending merger with Tilray (NASDAQ: TLRY) admittedly makes some sense.
Buying the Merger
For a moment, there was a merger-related case for APHA stock regardless.
Weak Earnings
The problem with having any concerns about the merger is that Aphria itself is coming off an ugly earnings report. Yet Aphria is the business that needs to do more of the heavy lifting post-merger.
Is APHA Stock Cheap?
Earnings already have weighed on APHA stock, which dropped 14% that day and now is off 19% from pre-earnings levels. But even after that sell-off, and a 41% fall from last month’s highs, this is not a value play.
What is the ticker symbol for Tilray?
After the merger completion, the new entity trades under Tilray’s ticker symbol, “TLRY” on both the US and Canadian stock exchanges. In a press release, Tilray said that the combined entity had proforma revenue of $685 million in the last year.
Is Aphria a Tilray?
Aphria has stopped trading and all Aphria shares are now converted to Tilray shares. The merger had got delayed due to the delay in approval from Tilray shareholders.